Simplex Trading, LLC Nuvalent, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 3,255 shares of NUVL stock, worth $282,794. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,255

Holding current value

$282,794

% of portfolio

0.01%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 08, 2024	BUY	$67.44 - $112.17 $219,517 - $365,113	3,255 New	3,255 $332,000
Q3 2023 Nov 01, 2023	BUY	$39.12 - $49.85 $413,146 - $526,465	10,561 New	10,561 $485,000

Others Institutions Holding NUVL

# of Institutions

209

Shares Held

59.5M

Call Options Held

450K

Put Options Held

619K

Deerfield Management Company, L.P. (Series C) New York, NY

20M
Shares

$1.74 Billion
38.02% of portfolio
Paradigm Biocapital Advisors LP New York, NY

5M
Shares

$434 Million
18.43% of portfolio
Vanguard Group Inc Valley Forge, PA

4.13M
Shares

$359 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.02M
Shares

$263 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

2.98M
Shares

$259 Million
7.96% of portfolio

View Full List

About Nuvalent, Inc.

Ticker NUVL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,977,800
Market Cap $3.73B
Description
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...

More about NUVL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account